Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 9INDUSTRY 3FED 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 2Breast 1

Conditions

Prostatic Neoplasms 68Prostatic Neoplasms, Castration-Resistant 6Metastatic Castration-resistant Prostate Cancer 6Neoplasms 4Metastatic Castration Resistant Prostate Cancer 4Urogenital Neoplasms 3Prostate Cancer Metastatic 3Neoplasm Metastasis 3Metastatic Castration-Resistant Prostate Cancer 3Genital Neoplasms, Male 3Breast Neoplasms 3Prostatic Diseases 2Neoplasms by Site 2Genital Diseases, Male 2Carcinoma, Non-Small-Cell Lung 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1NSCLC Harboring NRG1 Fusion 1Metastatic Castration-sensitive Prostate Cancer 1Metastatic Castration-resistant Prostate Neoplasms 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1Male Urogenital Diseases 1Hyperaldosteronism 1Colorectal Neoplasms 1Advanced Prostate Cancer 1Advanced Cancer 1Adenocarcinoma 1

Interventions

pembrolizumab 98Gemcitabine 70Paclitaxel 59Docetaxel 52Carboplatin 49Cisplatin 40Nivolumab 39Capecitabine 35Pemetrexed 33Fluorouracil 32Bevacizumab 32Cetuximab 31130-nm albumin-bound paclitaxel 28Trastuzumab 26Irinotecan 24Albumin-Bound Paclitaxel 24Fulvestrant 22Leucovorin 20Oxaliplatin 18Panitumumab 17abemaciclib 16Ipilimumab 16Cyclophosphamide 15cemiplimab 14atezolizumab 14Letrozole 14palbociclib 12Lapatinib 12Drug Therapy 12Doxorubicin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasm Metastasis × Abiraterone Acetate × Clear all
NCT04887506 2024-01-16

TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

Tavanta Therapeutics

Phase 3 Completed
107 enrolled 20 charts
Genitourinary

Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms

NCT02364531 2019-12-06

COSMiC

Janssen Inc.

Completed
194 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT01381874 2019-04-11

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Janssen Research & Development, LLC

Phase 2 Completed
297 enrolled 19 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡